Date of publication: November 03, 2021

Decision of the Secretary of Health: Approved

Pursuant to the role of the Health Technology Assessment Council (HTAC) to develop coverage recommendations particularly in the selection and financing of COVID-19 vaccines using the Evaluation Framework set by the HTAC, this report presents all currently available evidence considered in the assessment of COVID-19 Booster and Additional Dose. This assessment follows the HTAC evaluation framework to assess COVID-19 vaccines using the following criteria:

(1) responsiveness to magnitude and severity;

(2) clinical efficacy and safety;

(3) affordability and viability;

(4) household financial impact;

(5) social impact; and

(6) responsiveness to equity.

Evidence summary: Booster and Additional Dose Vaccination for the prevention of COVID-19